Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Markets & Finance

Bear Stearns Says 'Buy' UTI Worldwide


Bear Stearns sees a buying opportunity for UTI Worldwide (UTIW).

Analyst Edward Wolfe says UTI's closest public competitors, Expeditors International and EGL, pre-reported downside third-quarter results but saw relative strength in their stocks. In contrast, UTI didn't pre-report and sees a relatively strong third quarter. Wolf expects UTI to continue to grow its earnings before interest and taxes and earnings per share by two to three times faster than Expeditors has than in the last 10 quarters.

Wolfe notes investors increasingly are appreciating quality of UTI's management team and operating model, and he says stock pullbacks are becoming less frequent. He expects an accretive acquisition over the next quarter or so. Finally, he raised the $39 2004 year-end price target to $46.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus